Search

everythinglearnresearchcommunity

for

Search:↓

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

Systemic therapies improve nail psoriasis but have high side effects; more research is needed.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

Autosomal recessive woolly hair is rare and involves tightly coiled hair without other health issues.

Enteric hyperoxaluria can cause severe kidney failure after bowel surgery.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Most patients with dermatomyositis had skin rash, itching, and muscle weakness, treated mainly with prednisolone and hydroxychloroquine.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Signaling pathways are key targets for developing effective drugs.

α-Phellandrene may help prevent hair loss by increasing growth factors and cell growth in hair cells through a specific signaling pathway.

Targeting LPA could help treat skin disorders.

Phospholipids help plant proteins move by regulating receptor interactions.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

Dopamine receptors in the brain influence itch-related scratching behavior.

Dopamine stops hair growth and pigment production in human scalp hair follicles.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Hair loss may be linked to cardiovascular health problems.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Cyclic ADP-ribose helps regulate calcium and signals that promote hair growth in hair follicle cells.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

CCL5 is important for the hair growth potential of human dermal papilla cells.